Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Version label updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no evident changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-05-16T09:16:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a background site update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T17:09:28.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:08:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    IQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed, correcting the sponsor/collaborator listing.
    Difference
    0.0%
    Check dated 2026-04-10T09:13:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.3 to v3.5.0; no core study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-03-19T23:48:42.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added. No visible changes to the study details or page layout were observed.
    Difference
    0.0%
    Check dated 2026-03-12T20:14:02.000Z thumbnail image

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.